These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2472456)

  • 21. Efforts to produce human cytotoxic T-cell hybridomas by electrofusion and PEG fusion.
    Gravekamp C; Santoli D; Vreugdenhil R; Collard JG; Bolhuis RL
    Hybridoma; 1987 Apr; 6(2):121-33. PubMed ID: 3494659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of peptide-mediated electrofusion to select monoclonal antibodies directed against specific and homologous regions of the potyvirus coat protein.
    Werkmeister JA; Tebb TA; Kirkpatrick A; Shukla DD
    J Immunol Methods; 1991 Oct; 143(2):151-7. PubMed ID: 1719098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrofusion of single cells in picoliter droplets.
    Schoeman RM; van den Beld WTE; Kemna EWM; Wolbers F; Eijkel JCT; van den Berg A
    Sci Rep; 2018 Feb; 8(1):3714. PubMed ID: 29487332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directed fusion in hybridoma production.
    Reason D; Carminati J; Kimura J; Henry C
    J Immunol Methods; 1987 May; 99(2):253-7. PubMed ID: 3495603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of SCID-Hu mice and generation of anti-hepatitis B surface antigen-specific hybridomas by electrofusion.
    Neil GA; Sammons DW
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):201-5. PubMed ID: 1477301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microfluidic control of cell pairing and fusion.
    Skelley AM; Kirak O; Suh H; Jaenisch R; Voldman J
    Nat Methods; 2009 Feb; 6(2):147-52. PubMed ID: 19122668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
    Kato M; Sasamori E; Chiba T; Hanyu Y
    J Immunol Methods; 2011 Oct; 373(1-2):102-10. PubMed ID: 21878337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microscale production of hybridomas by hypo-osmolar electrofusion.
    Zimmermann U; Klöck G; Gessner P; Sammons DW; Neil GA
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):14-8. PubMed ID: 1576318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrofusion of B16-F1 and CHO cells: the comparison of the pulse first and contact first protocols.
    Usaj M; Flisar K; Miklavcic D; Kanduser M
    Bioelectrochemistry; 2013 Feb; 89():34-41. PubMed ID: 23032299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of human-mouse heterohybridomas against an immunising antigen.
    Jessup CF; Baxendale H; Goldblatt D; Zola H
    J Immunol Methods; 2000 Dec; 246(1-2):187-202. PubMed ID: 11121559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A biotin-streptavidin-biotin bridge dramatically enhances cell fusion.
    Li J; Yu X; Wagner TE; Wei Y
    Oncol Lett; 2014 Jul; 8(1):198-202. PubMed ID: 24959245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
    Tokunaga T; Chiba J; Ohnishi K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creating hybridomas by electrofusion.
    Glassy M
    Nature; 1988 Jun; 333(6173):579-80. PubMed ID: 3374603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells.
    Panova I; Gustafsson B
    Hybridoma; 1995 Jun; 14(3):265-9. PubMed ID: 7590790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in the research of cell electrofusion under microgravity].
    Sun Y; Yuan Y; Yi Z; Zhuang F; Fan Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):720-3. PubMed ID: 18693464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Production of anti-enteric adenovirus monoclonal antibody by electrofusion and semi-solid medium culture].
    Zhang Y; Chen L; Wang S; Guo C; Mao P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Mar; 11(1):69-71. PubMed ID: 15619911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How medium osmolarity influences dielectrophoretically assisted on-chip electrofusion.
    Hamdi FS; Français O; Dufour-Gergam E; Le Pioufle B
    Bioelectrochemistry; 2014 Dec; 100():27-35. PubMed ID: 25012938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybridoma technologies for antibody production.
    Tomita M; Tsumoto K
    Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in the basic technology of electrofusion for generation of antibody-producing hybridomas.
    Ohnishi K; Chiba J; Goto Y; Tokunaga T
    J Immunol Methods; 1987 Jun; 100(1-2):181-9. PubMed ID: 3110294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.